Please try another search
Race Oncology Limited, a clinical stage global biotechnology company, focuses on cancer care. Its lead product, bisantrene, is a small molecule anthracene chemotherapeutic. The company is developing bisantrene to address the unmet need of patients across multiple oncology indications, exploring anti-cancer plus cardio-protection. It is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway, following independent research describing bisantrene as the potent inhibitor of FTO (Fat mass and obesity-associated protein). The company is in collaboration with City of Hope, MD Anderson, Sheba City of Health, and UNC School of Medicine. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Nicholas George Kirk | 60 | 2004 | Chief Executive Officer, Managing Director and Executive Director |
Jack Theseus Lowenstein | 66 | 2000 | Non-Executive Director |
Anthony Vincent Connon | 71 | 2007 | Non-Executive Director |
D. Williams | - | 2014 | Non-Executive Director |
Stephen B. Humphrys | - | 2014 | Non-Executive Director |
R. B. Kelly | - | 2014 | Chairman |
Martin S. Tallman | - | 2016 | Member of Scientific Advisory Board |
Roland Walter | - | - | Member of Scientific Advisory Board |
Borje S. Andersson | - | 2019 | Chairman of Clinical Advisory Board |
Douglas Smith | - | - | Member of Scientific Advisory Board |
Jaap-Jan Boelens | - | 2020 | Member of Clinical Advisory Board |
James Breitenbucher | - | 2022 | Member of Scientific Advisory Board |
Phillip R. Lynch | - | 2020 | Non-Executive Director |
Jianjun Chen | - | 2021 | Member of Scientific Advisory Board |
Mary Harney | - | 2021 | Independent Non-Executive Chair |
Peter M. Smith | 60 | 2023 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review